Featuring References From
1.Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study https://www.bmj.com/content/362/bmj.k3851
2.Reversing Type 2 Diabetes and ongoing remission. https://www.ncl.ac.uk/magres/research/diabetes/reversal/#publicinformation
3.Diabetes poses an increased risk of amputations for sufferers https://www.diabetes.org.uk/about_us/news_landing_page/56000-people-with-diabetes-in-scotland-at-increased-risk-of-amputations/
4.Statement alerting patients and health care professionals of NDMA found in samples of ranitidine https://www.fda.gov/news-events/press-announcements/statement-alerting-patients-and-health-care-professionals-ndma-found-samples-ranitidine
5.Parekh, S., and T. Patel. (2019, September 23). The Zantac problem: What’s NDMA? https://abcnews.go.com/Health/zantac-problem-whats-ndma/story?id=65799147
6.NDMA Agency for Toxic Substances and Disease Registry. (n.d.). Public Health Statement. https://www.atsdr.cdc.gov/toxprofiles/tp141-c1.pdffc